18β-Glycyrrhetinic Acid: Bringing Science to the Forefront

How We Approach 18β-Glycyrrhetinic Acid in Our Facilities

Working in chemical manufacturing gives us a close look at the ways certain compounds rise in relevance across pharmaceutical and cosmetic production lines. Over years at the plant, I watch trends come and go, but 18β-Glycyrrhetinic Acid holds steady as a core ingredient in several demanding sectors. Many outside the lab hear “glycyrrhetinic acid” and picture licorice root extract, but there’s much more to this molecule once you walk through our production halls and speak with technicians on the floor.

We produce 18β-Glycyrrhetinic Acid in high purity grades, often greater than 98% as measured by HPLC. Color ranges from nearly white to off-white, which tells us about the extraction and crystallization steps. Dust levels, flow properties, and bulk density each get close attention, since these affect how easily downstream partners can incorporate the material into their processing equipment. Even particle size talks to us about mixing, dispersion, and even tableting performance.

Understanding the Identity: Why the 18β Isomer?

Glycyrrhetinic acid has two common isomers: 18α and 18β. In our experience, customers ask about this difference every week. Both share a similar backbone, and both originate in the plant Glycyrrhiza glabra—yet the β form carries distinct physical and biochemical qualities. 18β-Glycyrrhetinic Acid delivers better skin compatibility and stronger anti-inflammatory activity thanks to the spatial arrangement of atoms around carbon 18. The α isomer, while present in licorice extracts and at times as a byproduct, sees less use in pharmaceutical synthesis and skin-related research. For creams, gels, ointments, and even certain oral formulations, the β form offers greater safety data and published research, easing product registration tasks for our downstream partners.

Over decades of manufacturing both forms at pilot and production scale, we’ve witnessed processing challenges shift with each isomer. The 18β form processes more predictably, with fewer early-stage losses during purification and a more stable melting point—a key factor for consistent performance batch after batch. With the β form, less is lost in solid-liquid separations and crystallization steps, which translates to more efficient output and reliable purity.

Core Specifications and Lot Release Data

Inside the QA office, each lot gets checked using validated analytical methods. HPLC remains our gold standard for confirming purity, with UV detection set near 254 nm. Heavy metals get screened by ICP-MS, and moisture analysis follows Karl Fischer titration. Our final product leaves the factory with moisture content below 0.5% and typically less than 10 ppm combined heavy metals, often sitting near undetectable levels. Residual solvents, if any, stay below ICH Q3C guidelines. Particle size gets measured using sieve analysis for dry blends or laser diffraction for pharmaceutical clients. We designed these control points based on input from generic drug companies, contract manufacturers, and major cosmetic formulators—so laboratories can reduce their testing burden when validating a new lot.

Several clients tell us that this tight control lets them avoid troubleshooting step after step on their end. Whether their process includes direct blending, solution preparation, or granulation, our consistency shrinks the time from lot receipt to commercial production. The absence of off-odors and low ash content further lend flexibility in fragrance-sensitive applications or color-critical cosmetic lines.

Applications That Drive Real-World Value

The biggest impact of 18β-Glycyrrhetinic Acid comes from its use as an active pharmaceutical ingredient or as a functional additive in skin, oral, and hair care applications. Large volume medical and cosmetic producers look for this material when they want to claim anti-inflammatory, antibacterial, or corticosteroid-mimetic effects—most often labeled as either “glycyrrhetinic acid” or “licorice-derived bioactive.” In pharmaceuticals, it functions as both a primary and supporting compound in creams targeting dermatitis, eczema, or damaged mucosa. The benefit comes from its ability to inhibit certain enzymes associated with inflammation, as demonstrated in in vitro, animal, and early phase human studies.

In cosmetic and personal care products—especially those focused on brightening, barrier repair, or anti-redness—glycyrrhetinic acid’s documented support for the skin’s natural defense mechanisms leads formulators to both chiral and racemic versions, with the β form remaining dominant due to improved literature and established dose-response studies. Toothpaste and mouthwash blends sometimes incorporate very low concentrations of the acid for gum health and anti-irritation support, again leaning heavily on published research for regulatory filings and consumer claims.

Hair care lines targeting irritated or inflamed scalps occasionally use this ingredient, typically in product forms containing other natural extracts. We have worked with several OEM manufacturers to refine the acid’s dispersibility in both surfactant and water-based formulations, focusing on production practicality.

What Sets Our 18β-Glycyrrhetinic Acid Apart from Other Ingredients

Raw licorice root and some plant extracts deliver glycyrrhizin and glycyrrhetinic acid in small amounts, but the crude material contains a mix of saponins, polysaccharides, and unwanted plant residues. Extract concentration varies by plant source and harvest conditions. We eliminated those unpredictabilities by refining standardized extraction, defatting, and multi-stage purification protocols, allowing specifications to stand up in international audit settings or new chemical entity filings.

The market sometimes encounters synthetic analogues or lower-grade compounds from intermediate purification runs. These fail to achieve the trace impurity and microbial standards required for pharmaceutical or high-end cosmetic registrations, especially in Europe and North America. Chromatographic fingerprints show clear separation between enterprise-grade 18β-Glycyrrhetinic Acid and downgraded or agriculture-sourced product. Our batches deliver high purity, nearly absent plant debris, and undetectable pesticide residues. This reduces the compliance burden and limits contamination risks in finished formulations.

Some formulators try to substitute glycyrrhizin directly from licorice root for glycyrrhetinic acid, hoping to achieve a similar physiological effect. From our laboratory’s perspective, glycyrrhizin (the glycoside) must undergo enzymatic or chemical hydrolysis to yield glycyrrhetinic acid, which introduces instability and batch-to-batch irregularity. By supplying the free acid, we remove those uncertainties and help partners avoid late-stage production failures or unplanned regulatory questions.

Commitment to Traceability and Manufacturing Rigor

Every step in our supply chain is documented, from root harvest through to the final crystalline acid. We audit suppliers under Good Agricultural and Collection Practices. Only select batches of Glycyrrhiza glabra or similar species pass into our extraction line—avoiding species known to vary in glycyrrhetinic acid content or present cross-contamination risk. Extraction follows standardized protocols with routine chemical and microbial monitoring at critical points.

The manufacturing process incorporates repeated centrifugal extraction, clarification, and a sequence of filtration and chromatographic steps. Every modification—whether in temperature, solvent ratio, or filter choice—draws from our engineers’ cumulative decades in active ingredient production, including earlier work on corticosteroids and triterpenoids. In-process control maintains pH, solid resin activation, and pressure differentials within validated windows. Final crystallization occurs under strict environmental controls, limiting exposure to moisture and contaminants so the finished powder meets predetermined criteria on particle size, residual solvents, and chemical stability.

Released batches carry complete documentation, including process records, batch analysis, and shipment traceability. We retain reserve samples and maintain analytical records according to current GMP guidelines. Our customers conducting regulatory submissions or facing ingredient audits receive supporting documentation rapidly. By using only food or pharmaceutical grade solvents and avoiding controversial chemicals in the process, we support downstream market approvals in a broad set of countries.

Consistency and Batch-to-Batch Reliability

Customers depend on consistent feedstock for all their large-scale production cycles. An unreliable supply of 18β-Glycyrrhetinic Acid leads to costly recalibration of blending, testing, and finished product qualification. Our team knows the cost of an out-of-specification batch, both in terms of lost time and wasted raw material. Through deep process validation and robust plant controls, we maintain narrow controls over all vital characteristics—purity, water content, and presence of process-related impurities.

We analyze process deviations after every cycle, investigating root causes, corrective actions, and preventive measures, drawing on lessons documented since the company’s foundation. In addition, our staff perform trend analysis for every critical parameter, so we can intervene before minor inconsistencies affect output. These efforts allow our 18β-Glycyrrhetinic Acid to meet demanding regulatory and customer requirements for use in marketed drugs, medical devices, or high-value personal care launches.

Safety and Regulatory Perspectives

As a manufacturer, chemical safety sits at the core of each operational discussion. We monitor the evolving regulatory frameworks surrounding glycyrrhetinic acid, including its permitted use levels, warning requirements, and accepted claims. Most global regulatory agencies—such as the FDA, EMA, and CFDA—permit topical use up to published thresholds for active ingredients or as an excipient subject to risk assessment. Published toxicological reviews and clinical trial reports form the basis for our risk communication documents supplied to customers on request.

Onsite toxicologists review emerging adverse event data, new studies, and monograph changes. If new findings indicate any risk or restriction, we adapt our release and compliance protocols to address those issues. Our ability to support customers with transparent data contributes to long-term relationships and helps bridge the gap between chemical production and downstream risk management.

Environmental Responsibility in Extraction and Refining

Scaling extraction and purification throughout the years brought significant challenges regarding waste streams and environmental impact. Early on, organic solvent waste, solid effluents, and high energy use hampered sustainability efforts. Over time, we developed solvent recovery and recycling systems that now reclaim the majority of used extraction media, lowering both cost and environmental burden.

Plant material left after glycyrrhetinic acid extraction gets composted or reused in industrial applications, ensuring our operation does not contribute to hazardous bio-waste in local municipalities. Filter aids and column resins are selected with end-of-life disposal in mind, balancing separation performance with minimize downstream toxicity and chemical leaching. Members of our technical team participate in regional industrial sustainability forums, sharing lessons learned and adopting new best practices as regulations and technologies evolve.

Responding to Market and Scientific Shifts

Demand for 18β-Glycyrrhetinic Acid continues to rise in both established and emerging markets. New therapeutic and cosmetic research brings up potential applications, from photoprotection to wound healing. We field questions from both startup labs and global corporations about unique formulations, specialty grades, or custom documentation. Our R&D staff review recent clinical literature, evaluate our own pilot data, and meet with innovation teams regularly to adjust grade characteristics—in some cases supplying lower dust, alternate particle size distributions, or grades made without certain reagents to fit vegan or animal product-free claims.

As major customers look to meet consumer interest in “natural” and “plant-derived” actives, we receive regular audits on traceability and sustainability. Years of documentation and association memberships make these verifications routine, so our partners can make their own downstream claims with confidence, knowing independent third parties have reviewed our supply chain.

Supporting Formulators and Product Developers

Each batch of 18β-Glycyrrhetinic Acid ships with supporting data packages, letting formulation teams assess solubility, compatibility, and reactivity with other ingredients. Our product development experts answer technical questions, from dissolution rates to reaction risks in multi-phase blends. In collaborative projects with pharma and personal care companies, we run scaled testing in application labs to give concrete starting points for successful end-product development.

Through years of troubleshooting common sticking points—grit, clumping, unexpected reactivity, or smell drift—we help reduce lost time and project cost for formulators. Cosmetic chemists appreciate guidance on dispersing the acid in viscous creams, where uniform distribution at a reactive pH requires more than just mixing. Pharmaceutical teams benefit from detailed mass balance, impurity profiling, and solvent residue support, easing the registration of new generics or combo-product launches.

Navigating Price and Supply Volatility

The glycyrrhetinic acid supply chain is subject to seasonal and geopolitical risks. Climate disruptions and policy changes can alter licorice root availability in growing regions, raising both price and lead time unpredictably. By maintaining both multiple raw material sources and finished good inventory, we partly shield customers from sudden spikes. Our procurement managers maintain relationships directly with farm co-ops and established growers, which gives us more negotiating leverage and foresight into future disruptions.

The past decade showed us that single-source dependency leads to customer disappointment and broken launch schedules. Flexible contracts, transparent communication, and pre-booked raw materials help keep order fulfillment on track for existing contracts and new inquiries even when the wider market runs tight.

Looking Ahead: The Evolving Role of 18β-Glycyrrhetinic Acid

From a manufacturing viewpoint, 18β-Glycyrrhetinic Acid occupies an increasingly strategic space in modern health and beauty products. Technical knowledge born from years of consistent supply, responsive support, and adherence to evolving regulatory frameworks keeps our product relevant and trusted by leading brands. As research pushes new applications for tissue repair, immune modulation, and inflammation, our facility adapts by investing in better control technologies and documentation systems.

We continue to learn alongside our downstream partners, aiming to keep 18β-Glycyrrhetinic Acid a reliable building block in future formulations—rooted in plant chemistry and strengthened by reproducible science. Watching this material move from dusty roots in rural fields to gleaming vials and jars in modern laboratories still brings a sense of pride and curiosity—a drive to keep improving the journey from raw nature to finished product.